Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9937439 | 0.81 | HTT (0.46) | TSHRALDH1A1SMN1; SMN2HTT | |
| SCHEMBL9936671 | 0.79 | HTT (0.31) | HTT | |
| SCHEMBL13141065 | 0.78 | TSHR (0.38) | TSHRALDH1A1CA2HTT | |
| SCHEMBL16917836 | 0.76 | MAPK1 (0.33) | MAPK1HIF1AALDH1A1TP53CYP3A4 | |
| SCHEMBL2600806 | 0.76 | NAAA (0.39) | MAPK1HIF1AALDH1A1 | |
| SCHEMBL23471219 | 0.76 | KDM4E (0.38) | CA2 | |
| SCHEMBL9937986 | 0.76 | — | — | |
| SCHEMBL9630407 | 0.76 | MEN1 (0.30) | MAPK1HIF1ATSHRALDH1A1CYP3A4 | |
| SCHEMBL12172802 | 0.76 | — | — | |
| SCHEMBL20664518 | 0.75 | TSHR (0.46) | MAPK1HIF1ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7683202-B2 | Permanent surface modifiers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-03-23 | — | — | US | disclosed |
| US-20080249252-A1 | New permanent surface modifiers | PICCINELLI PIERO | 2008-10-09 | — | — | US | disclosed |
| US-7408077-B2 | Permanent surface modifiers | CIBA SPECIALTY CHEMICALS CORP. (US) | 2008-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080249252-A1 | New permanent surface modifiers | SGMS1, SGMS2, PLIN5 | MAPK1 3540/4885HIF1A 1817/4885TSHR 3501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.